IGF1 serum levels were significantly higher in melanoma patients and correlated with Breslow depth, identified as a prognosis factor [65], but a recent large study did not find a correlation of IGF1 serum level with melanoma risk [66]. The gene discussed is IGF1; the disease is melanoma.